E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPOPIO0106(Opioid peptide)
DFBP ID DFBPOPIO0106
Peptide sequence YPFPGP
Type Native peptide
Peptide/Function name Opioid peptide, β-Casomorphin-6
Function-activity relationship
Main bioactivity Opioid activity
Otheir bioactivity DPP IV-inhibitory activity [D1], Multifunctional activity [D2]
Calculated physicochemical properties
Three-letter amino acid Tyr-Pro-Phe-Pro-Gly-Pro
Single-letter amino acid YPFPGP
Peptide length 6
Peptide mass
Experimental mass Theoretical mass
N.D 676.76 Da c
Net charge 0.00 c
Isoelectric point (pI) 5.92 c
IC50 N.D
pIC50 N.D
GRAVY -0.6167 c
Hydrophilic residue ratio 83.33% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Bovine milk protien
Precursor protein β-Casein
Residue position

f(60-65)

Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Opioid activity

The heptapeptide YPFPGP showed potently opioid agonist activity for μ-opiate receptor [1,3]

Table 1. Opioid activity of synthesis products, and, for comparison, peptides isolated from bovine casein peptone.
Substance
Opioid activity a
Synthesis product with free carbosyl group
Isolated product from casein peptone
YPFPGPI
57.0 ± 7.5
55.0 ± 6.9
YPFPGP
27.4 ± 1.7
YPFPG
6.5 ± 0.6
5.0 ± 0.8
YPFP
21.9 ± 2.6
YPF
> 200
> 200
YP
> 200
Methionine-enkephalin
0.19 ± 0.02
Normorphine
0.23 ± 0.02
a The values indicate the substance concentrations in μΜ which effected a 50% inhibition of electrically induced contractions of the guinea pig ileum longitudinal muscle-myenteric plexus preparation. All inhibitons proved to be antagonisable by the specific opiate antagonist naloxone. For comparison methionine-enkephalin and normorphine are listed.
Specific target protein(s) Specific Target Protein(s):
Mu-type opioid receptor
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N1[C@@]([H])(CCC1)C(=O)NCC(=O)N1[C@@]([H])(CCC1)C(=O)O
Preparation method
Mode of preparation

Enzymatic hydrolysis

Enzyme(s)/starter culture

Bovine milk protein was hydrolysis with pepsin.

Stability & Cytotoxicity
Peptide stability
Literature report:

The opioid peptide was highly resistant towards proteolysis, even by pronase.

EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information

The sequence of bovine β-casein (59-81) is -LVYPFPGPI-Pro67/His67-NSLPQNIPPLTQTP- [5].

Database cross-references
DFBP
[D1] DFBPDPIV0197
[D2] DFBPMUFU0734
BIOPEP-UWM [D3] -
APD [D4] -
BioPepDB [D5] -
MBPDB [D6] -
Reference(s)
Primary literature Lottspeich F, Henschen A, Brantl V, Teschemacher H. Novel opioid peptides derived from casein (beta-casomorphins). III. Synthetic peptides corresponding to components from bovine casein peptone. Hoppe Seylers Z Physiol Chem. 1980 Dec;361(12):1835-9.
PMID: 7461609
Other literature(s)

[1] Kostyra E, Sienkiewiczszłapka E, Jarmołowska B, et al. Opioid peptides derived from milk proteins.[J]. Polish Journal of Food & Nutrition Sciences, 2004.
[2] Meisel H, Frister H, Schlimme E. Biologically active peptides in milk proteins.[J]. Zeitschrift Für Ernährungswissenschaft, 1989, 28(4):267.
[3] Schlimme E, Meisel H. Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects.[J]. Nahrung, 1995, 39(1):1-20.
[4] Jinsmaa Y., Yoshikawa M., Enzymatic release of neocasomorphin and β-casomorphin from bovine β-casein. Peptides, 1999, 20, 957–962.
[5] Jinsmaa Y, Yoshikawa M. Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein.[J]. Peptides, 1999, 20(8):957.

PubDate 1980
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214